AGENT CAPITAL, LLC
AGENT CAPITAL, LLC is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US writing $500K–$15M checks into Healthcare and life-sciences.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, life-sciences
- Check size
- $500K–$15M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $63.5M
- Website
- agentcapital.com
Thesis
Agent Capital is a healthcare venture capital firm that invests in novel and differentiated therapeutics and treatments addressing unmet patient needs. Founded in 2016 or 2017, the firm is based in Waltham, Massachusetts, and focuses on early-stage healthcare investments across the United States. Agent Capital invests across all development stages, from preclinical to commercial, with key investment areas including rare diseases, oncology, neurology, and immunology. Agent Capital Fund I has $63.5M assets under management. In 2021, they raised $59.55 million for its second fund, targeting $100 million. In 2017, Agent Capital had raised $25 million for its Agent Capital Fund I, with a target of $100 million.
Common questions
Does AGENT CAPITAL, LLC invest at the Pre-seed stage?
Yes. AGENT CAPITAL, LLC lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does AGENT CAPITAL, LLC write?
AGENT CAPITAL, LLC writes $500K–$15M checks.
Where does AGENT CAPITAL, LLC invest?
AGENT CAPITAL, LLC invests in the US.